Shingrix is administered intramuscularly (IM)
Shingrix (recombinant zoster vaccine) must be given intramuscularly, specifically in the deltoid region of the upper arm. This is explicitly stated in the FDA-approved prescribing information and is non-negotiable for proper vaccine administration 1.
Administration Details
The vaccine is administered as follows:
- Route: Intramuscular injection only at a 90-degree angle
- Site: Deltoid muscle of the upper arm (preferred site)
- Dose: 0.5 mL per dose
- Schedule: Two doses given 2-6 months apart (or 1-2 months apart for immunocompromised individuals) 1
Why IM and Not SC?
Vaccines containing adjuvants like Shingrix must be injected into muscle mass. When administered subcutaneously or intradermally, adjuvanted vaccines can cause local irritation, induration, skin discoloration, inflammation, and granuloma formation 2. Shingrix contains the AS01B adjuvant system, which requires intramuscular administration for optimal immunogenicity and to minimize adverse local reactions 1.
Research comparing subcutaneous versus intramuscular administration of the herpes zoster subunit vaccine demonstrated that while immune responses were comparable, local reactogenicity (particularly grade 3 redness and swelling) was significantly greater with subcutaneous administration 3. This finding reinforces the importance of following the approved intramuscular route.
Critical Administration Points
- The needle must be long enough to reach muscle mass and prevent vaccine from seeping into subcutaneous tissue 2
- For adults, a 1 to 1½ inch needle is typically appropriate for deltoid injection 2
- Never administer in the gluteal region, as this has been associated with decreased immunogenicity for other vaccines and poses risk of sciatic nerve injury 2
Common Pitfall to Avoid
Do not confuse Shingrix (recombinant zoster vaccine) with the older live-attenuated zoster vaccine (Zostavax), which was administered subcutaneously. Shingrix replaced Zostavax as the preferred vaccine and has a completely different administration route 4, 5.